<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-biomedicines-08-00060">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Robert</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Long</surname>
    <given-names>G.V.</given-names>
   </name>
   <name>
    <surname>Brady</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Dutriaux</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Maio</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Mortier</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hassel</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Rutkowski</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>McNeil</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Kalinka-Warzocha</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Nivolumab in previously untreated melanoma without 
   <italic>BRAF</italic> mutation
  </article-title>
  <source>N. Engl. J. Med.</source>
  <year>2015</year>
  <volume>372</volume>
  <fpage>320</fpage>
  <lpage>330</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1412082</pub-id>
  <pub-id pub-id-type="pmid">25399552</pub-id>
 </element-citation>
</ref>
